Neuromuscular Diseases Clinical Trial
Official title:
Energetic, a Self Management Group Program Aimed at Reconditioning and Social Participation in Persons With a Muscle Disease; a Multicentre Randomized Controlled Trial.
| Verified date | April 2016 |
| Source | Radboud University |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Interventional |
Fatigue is present in at least 60% of the patients with a muscle disease and can be the most disabling symptom. In combination with other impairments, this often results in low levels of physical activity and decreased social participation, leading to large societal costs. Energetic is a self-management group program aimed at improving participation and physical endurance in these patients. Our hypothesis is that Energetic results in improved participation and improved physical endurance, less experienced fatigue and better quality of life compared to usual care, without increasing health care costs.
| Status | Completed |
| Enrollment | 53 |
| Est. completion date | May 2017 |
| Est. primary completion date | November 2016 |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | 18 Years to 85 Years |
| Eligibility |
Inclusion Criteria: - formal diagnosis of muscular disease, either FascioScapuloHumeral Dystrophy (FSHD), Inclusion Body Myositis (IBM), Mitochondrial Myopathy (MM) or any other; - being severely fatigued - being cardiopulmonary stable and capable of aerobic training (as determined using a submaximal cycling exercise test with ECG (electrocardiography) and advice from a consultant cardiologist and pulmonologist); - being motivated, committed to the program, and 'ready to change' which is discussed with the patient during the screening by a rehabilitation physician and an occupational therapist; to this end, motivational interviewing will be used (including a advantages/disadvantages matrix; a visual analogue scale (VAS) to rate the importance of participation in de program; and a VAS to rate the confidence a patient has that participation in the program is feasible) - being able to formulate at least 3 individual participation goals during the interview with the occupational therapist. Exclusion Criteria: - active depression or other psychiatric disorder as indicated by a consultant psychologist or by the medical history, - pregnancy, - severe co-morbid condition, - having participated in the Energetic program before - a travel distance perceived as too burdensome |
| Country | Name | City | State |
|---|---|---|---|
| Netherlands | Radboudumc | Nijmegen | Gelderland |
| Lead Sponsor | Collaborator |
|---|---|
| Radboud University | Center of expertise Sneller herstel, Revalidatiefonds Nederland, ZonMw: The Netherlands Organisation for Health Research and Development |
Netherlands,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Canadian Occupational Performance Measure (COPM) | Perceived activity performance. Three months will be the primary analysis. Effects at follow up will be measured at 6 and 12 months (see secondary outcome measures) (patient) | 3 months | |
| Secondary | Canadian Occupational Performance Measure (COPM-satisfaction) | Perceived satisfaction with performance (patient) | 3 months | |
| Secondary | Canadian Occupational Performance Measure (COPM-satisfaction) | Perceived satisfaction with performance (patient) | 6 months | |
| Secondary | Canadian Occupational Performance Measure (COPM-satisfaction) | Perceived satisfaction with performance (patient) | 15 months | |
| Secondary | Canadian Occupational Performance Measure (COPM-performance) | Perceived performance in activities. Is primary outcome measure at 3 months, but data of 6 and 15 months follow up wil be used in a secondary analysis. (patient) | 6 months | |
| Secondary | Canadian Occupational Performance Measure (COPM-performance) | Perceived performance in activities. Is primary outcome measure at 3 months, but data of 6 and 15 months follow up wil be used in a secondary analysis. (patient) | 15 months | |
| Secondary | Activity Card Sort (ACS) | Participation measure:% retained activities.(patient) | 3 months | |
| Secondary | Activity Card Sort (ACS) | Participation measure:% retained activities.(patient) | 6 months | |
| Secondary | Activity Card Sort (ACS) | Participation measure:% retained activities.(patient) | 15 months | |
| Secondary | Six Minutes Walking Test (6MWT) | physical endurance, sub-max test. (patient) | 3 months | |
| Secondary | Six Minutes Walking Test (6MWT) | physical endurance, sub-max test. (patient) | 6 months | |
| Secondary | Six Minutes Walking Test (6MWT) | physical endurance, sub-max test. (patient) | 15 months | |
| Secondary | Health care cost | Evaluation health care cost (patient) | 3 months | |
| Secondary | Health care cost | Evaluation health care cost (patient) | 6 months | |
| Secondary | Health care cost | Evaluation health care cost (patient) | 15 months | |
| Secondary | Checklist Individual Strength subscale fatigue (CIS-fatigue) | Impact of fatigue (patient) | 3 months | |
| Secondary | Checklist Individual Strength subscale fatigue (CIS-fatigue) | Impact of fatigue (patient) | 6 months | |
| Secondary | Checklist Individual Strength subscale fatigue (CIS-fatigue) | Impact of fatigue (patient) | 15 months | |
| Secondary | Health-related Quality of Life: Short Form 36 (SF-36) | Quality of life, used for evaluation of cost effectiveness (patient) | 3 months | |
| Secondary | Health-related Quality of Life: Short Form 36 (SF-36) | Quality of life, used for evaluation of cost effectiveness (patient) | 6 months | |
| Secondary | Health-related Quality of Life: Short Form 36 (SF-36) | Quality of life, used for evaluation of cost effectiveness (patient) | 15 months | |
| Secondary | General Self-Efficacy Scale | Evaluation of the perceived self-efficacy (patient) | 3 months | |
| Secondary | General Self-Efficacy Scale | Evaluation of the perceived self-efficacy (patient) | 6 months | |
| Secondary | General Self-Efficacy Scale | Evaluation of the perceived self-efficacy (patient) | 15 months | |
| Secondary | Hospital Anxiety and Depression Scale (HADS) | Anxiety and depression (patient) | 3 months | |
| Secondary | Hospital Anxiety and Depression Scale (HADS) | Anxiety and depression (patient) | 6 months | |
| Secondary | Hospital Anxiety and Depression Scale (HADS) | Anxiety and depression (patient) | 15 months | |
| Secondary | Zarit Burden Inventory (ZBI) | Perceived caregiver burden (caregiver) | 3 months | |
| Secondary | Zarit Burden Inventory (ZBI) | Perceived caregiver burden (caregiver) | 6 months | |
| Secondary | Zarit Burden Inventory (ZBI) | Perceived caregiver burden (caregiver) | 15 months |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT03548779 -
North Carolina Genomic Evaluation by Next-generation Exome Sequencing, 2
|
N/A | |
| Completed |
NCT04435093 -
Digitalization Playful Module of Motor Function Measure Assessment for Children With Neuromuscular Disorders, MFM-Play Pilot Study.
|
||
| Not yet recruiting |
NCT04089696 -
Validation of the "ExSpiron©" in Patients With ALS
|
N/A | |
| Not yet recruiting |
NCT05785546 -
Elaboration of a Pronostic Score of Changes on Wheelchair's Seating System
|
||
| Completed |
NCT01313325 -
Hippotherapy to Improve the Balance of Children With Movement Disorders
|
N/A | |
| Recruiting |
NCT04098094 -
Outcomes of RV Dysfunction in Acute Exacerbation of Chronic Respiratory Diseases
|
||
| Active, not recruiting |
NCT05070624 -
The Peer Support Study
|
N/A | |
| Completed |
NCT04729920 -
Home Use of Mechanical Insufflation/Exsufflation Devices in Neuromuscular Diseases
|
||
| Recruiting |
NCT04581577 -
Perceptions of the Clinical and Psychosocial Impact of Covid-19 in Patients With Neuromuscular and Neurological Disorders
|
||
| Completed |
NCT06428864 -
Effect of the Use of a 3D Scanner Application on a Smartphone to Mold Garchois Orthotic Device in Neuromuscular Diseases Patients With Scoliosis
|
||
| Enrolling by invitation |
NCT05539456 -
Reliability and Validity of the Turkish Version of the PedsQL 3.0 Neuromuscular Module for 2-to 4- Year-old
|
||
| Completed |
NCT05353738 -
Efficacy of Vaccination Against COVID-19 in Patients Presenting a Neuromuscular Disease With Severe Amyotrophy
|
||
| Recruiting |
NCT04541602 -
Detection of Neuromuscular Complications in Critically Ill Patients
|
||
| Completed |
NCT03394859 -
Electronic Medical Records and Genomics (eMERGE) Phase III
|
||
| Enrolling by invitation |
NCT05099107 -
Changes of Motor Function Tests in Congenital Myopathy Subjects Treated With Oral Salbutamol as Compared to no Treatment
|
N/A | |
| Completed |
NCT05070910 -
NDT Effectiveness Study
|
N/A | |
| Recruiting |
NCT04100993 -
Multisystem and Autonomic Complications of NMD on Long-term NIV
|
||
| Recruiting |
NCT04986059 -
Effects of Pre-event Massage on Muscle Activity
|
N/A | |
| Completed |
NCT01022931 -
Epidemiology and Clinical Presentation of H1N1 Infection in Children in Geneva
|
N/A | |
| Terminated |
NCT03353064 -
Telemedicine for Improving Outcome in Inner City Patient Population With Hypercapneic Respiratory Failure
|
N/A |